发明名称 Oxidized cardiolipin as a novel pro-inflammatory factor
摘要 <p>Low levels of antibodies reactive with oxidised Cardiolipin (oxCL) in mammals are related to an increased risk of developing cardivacular diseases, auto-immune diseases or inflammatory conditions. High levels can have a protective function and in general there is a negative association between manifestations of these conditions and antibodies against oxCL. Thus, based on their relations methods of monitoring, determining and diagnosing as well as methods of immunisation and therapy of these diseases and conditions are provided.</p>
申请公布号 EP2711705(A1) 申请公布日期 2014.03.26
申请号 EP20130188367 申请日期 2009.12.21
申请人 MEDIRISTA BIOTECHNOLOGIES AB 发明人 FROSTEGAARD, JOHAN
分类号 G01N33/564;A61K31/00;A61K38/00;A61K39/00;A61P9/00;A61P25/00;A61P29/00 主分类号 G01N33/564
代理机构 代理人
主权项
地址